Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Audrey‐Anne Lamoureux
Observed name:
Audrey-Anne Lamoureux
Institutions:
Centre Hospitalier Universitaire Sainte-Justine,
Université de Montréal
Observed institutions:
Centre Hospitalier Universitaire Sainte-Justine,
CHU Sainte-Justine Research Center,
Université de Montréal
ORCID:
0009-0008-3878-8995
Observed ORCID:
0009-0008-3878-8995
OpenAlex ID:
A5083223931
Magnetic resonance‐guided laser interstitial thermal therapy for drug‐resistant epilepsy: A systematic review and individual participant data meta‐analysis
2023
·
Jia‐Shu Chen
, Audrey‐Anne Lamoureux
, et al.
·
Epilepsia
·
40
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2024
·
Audrey-Anne Lamoureux
, Michael J. Fisher
, et al.
·
Clinical Cancer Research
·
15
PDF
Pediatric Delirium: An Overlooked Diagnosis?
2023
·
Audrey-Anne Lamoureux
, Laurence Ducharme-Crevier
, et al.
·
Pediatric Neurology
·
10
Epid-10. Cnsontrk Study: Clinical Characteristics and Outcome of Central Nervous System Tumors Harboring Ntrk Gene Fusions
2023
·
Audrey-Anne Lamoureux
, Michael Fisher
, et al.
·
Neuro-Oncology
·
1
PDF
Clinical Features and Outcomes of Central Nervous System Tumors with NTRK Gene Fusions (S29.005)
2025
·
Pouneh Amir Yazdani
, Audrey-Anne Lamoureux
, et al.
·
Neurology
Supplementary Table S2 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
·
Audrey-Anne Lamoureux
, Michael J. Fisher
, et al.
Supplementary Table S3 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
·
Audrey-Anne Lamoureux
, Michael J. Fisher
, et al.
Supplementary Table S1 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
·
Audrey-Anne Lamoureux
, Michael J. Fisher
, et al.
Data from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
·
Audrey-Anne Lamoureux
, Michael J. Fisher
, et al.
Supplementary Figure S1 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
·
Audrey-Anne Lamoureux
, Michael J. Fisher
, et al.
Supplementary Figure S2 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
·
Audrey-Anne Lamoureux
, Michael J. Fisher
, et al.
Supplementary Table S4 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
·
Audrey-Anne Lamoureux
, Michael J. Fisher
, et al.
Supplementary Table S5 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
·
Audrey-Anne Lamoureux
, Michael J. Fisher
, et al.
Supplementary Data S1 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
2025
·
Audrey-Anne Lamoureux
, Michael J. Fisher
, et al.
HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.
2022
·
Audrey-Anne Lamoureux
, Michael Fisher
, et al.
·
Neuro-Oncology
PDF
Clinical characteristics and outcome of a large cohort of patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.
2022
·
Audrey-Anne Lamoureux
, Michael J. Fisher
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
16
Citation count:
66
H-index:
3
I10-index:
3
Year
Topic
Type